Is chronic kidney disease stage 5 considered end‑stage renal disease (ESRD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CKD Stage 5 and ESRD/ESRF: Terminology and Clinical Equivalence

Yes, CKD Stage 5 is clinically equivalent to what was historically called end-stage renal failure (ESRF) or end-stage renal disease (ESRD), but modern guidelines explicitly recommend abandoning the "end-stage" terminology in favor of "kidney failure" or "CKD Stage 5." 1

Why the Terminology Has Changed

The KDIGO 2020 consensus conference unanimously agreed that "kidney failure" should replace all "end-stage" terminology because ESRD/ESRF are poorly defined, inconsistently used, and misleadingly imply that death is imminent even though patients can survive for years with treatment. 1, 2

  • The terms ESRD and ESRF are explicitly listed as "terms to avoid" in the KDIGO nomenclature guidelines. 1, 2
  • These terms carry stigma and create confusion because they are used administratively (for Medicare coverage eligibility in the US) rather than as precise medical definitions. 2
  • ESRD/ESRF technically only applies to patients receiving dialysis or transplantation, excluding patients with identical kidney dysfunction who are not treated by choice, lack of access, or who receive conservative management. 2

The Correct Modern Definition

CKD Stage 5 (kidney failure) is defined as GFR <15 mL/min/1.73 m² or treatment by dialysis, representing loss of more than 85% of kidney function. 1, 3, 2

  • This definition applies regardless of whether the patient is receiving kidney replacement therapy. 1
  • Further specification is required beyond just the GFR threshold: duration of disease (>3 months to distinguish from acute kidney injury), presence or absence of uremic symptoms, and treatment status. 1, 3

How to Properly Document CKD Stage 5

Use the nomenclature "CKD G5" with additional descriptors to specify treatment status: 1, 2

  • CKD G5D = CKD Stage 5 treated by dialysis (replaces "ESRD on dialysis") 1
  • CKD G1T–G5T = CKD after kidney transplantation at any GFR level (replaces "ESRD with transplant") 1
  • CKD G5 without KRT = Kidney failure not receiving kidney replacement therapy, whether by patient choice, unavailability, or comprehensive conservative care 1, 3

Clinical Implications of the Distinction

The shift from ESRD/ESRF to CKD Stage 5 terminology reflects that kidney failure is a clinical state requiring specification of symptoms and treatment, not just a GFR threshold. 3, 2

  • Patients with GFR <15 mL/min/1.73 m² may remain stable without dialysis for months to years, particularly with multidisciplinary nephrology care including dietary counseling, RAS blockade, and symptom management. 3, 4, 5
  • Dialysis initiation should be based on clinical symptoms (uremic symptoms, refractory fluid overload, uncontrolled hypertension, progressive malnutrition, severe electrolyte abnormalities) rather than GFR threshold alone. 3
  • Starting dialysis at higher GFR values in asymptomatic patients does not improve survival and may accelerate loss of residual kidney function due to hemodialysis-related hypotension. 3

Common Pitfalls to Avoid

Never use ESRD, ESRF, ESKD, or ESKF in clinical documentation—these are outdated terms that KDIGO explicitly recommends avoiding. 1, 2

Do not assume all patients with GFR <15 mL/min/1.73 m² are receiving or need dialysis—always specify treatment status explicitly. 2

Do not initiate dialysis based solely on reaching GFR <15 mL/min/1.73 m² without clinical symptoms, as this threshold alone does not mandate treatment. 3

Always calculate eGFR using validated equations (MDRD or CKD-EPI) rather than relying on serum creatinine alone, as creatinine-based estimates can overestimate residual renal function when GFR is severely impaired in up to 36% of cases. 3, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clinical Distinctions Between ESRF and CKD Stage 5

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

CKD Stage 5 and ESRF Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.